(Q35076594)

6 August 2017

1 reference

title

Current pharmacotherapy for the treatment of severe burns (English)

1 reference

6 August 2017

0 references

Kevin D Murphy

1

1 reference

6 August 2017

Jong O Lee

series ordinal

2

1 reference

6 August 2017

David N Herndon

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Expert Opinion on Pharmacotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

4

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

369-384

1 reference

The epidemiology of burns and smoke inhalation in secondary care: a population-based study covering Lancashire and South Cumbria

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Burn prevention: the need for a comprehensive approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Adjunctive methods of pain control in burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Pain relief with low-dose intravenous clonidine in a child with severe burns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Clonidine for treatment of postoperative pain: a dose-finding study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Relationship between acute morphine and the course of PTSD in children with burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Use of patient-controlled analgesia with alfentanil for burns dressing procedures: a preliminary report of five patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Patient-controlled analgesia: an appropriate method of pain control in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Etomidate for pediatric sedation prior to fracture reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Standard treatment: the role of antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Burn wound itch control using H1 and H2 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Safety and pharmacokinetics of EMLA in the treatment of postburn pruritus in pediatric patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

The use of TENS for pruritus relief in the burns patient: an individual case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Psychiatry of the medically ill in the burn unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Treatment for posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

The effectiveness of risperidone on acute stress symptoms in adult burn patients: a preliminary retrospective pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Bactericidal and Wound-Healing Properties of Sodium Hypochlorite Solutions: The 1991 Lindberg Award

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

An open study comparing topical silver sulfadiazine and topical silver sulfadiazine-cerium nitrate in the treatment of moderate and severe burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

An outbreak of extended-spectrum, beta-lactamase-producing Salmonella senftenberg in a burns ward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Cutaneous copper and zinc losses in burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Zinc deficiency and immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Low ceruloplasmin levels during recovery from major burn injury: influence of open wound size and copper supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Metabolic and immune effects of enteral ascorbic acid after burn trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Role of acid suppressants in intensive care medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine [correction of acetylcystine] therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Persistence of muscle catabolism after severe burn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Catecholamines: mediator of the hypermetabolic response to thermal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Growth hormone and IGF-I therapy in the hypercatabolic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Testosterone administration in severe burns ameliorates muscle catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Anabolic effects of oxandrolone after severe burn

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Effects of beta-blockade on energy metabolism following burns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Improved myocardial oxygen utilization following propranolol infusion in adolescents with postburn hypermetabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

Reversal of catabolism by beta-blockade after severe burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.3.369

21 January 2018

Identifiers

DOI

10.1517/14656566.4.3.369

1 reference

6 August 2017

1 reference